Early-Stage cancer drug trial halted after just 3 patients
Disease control
Terminated
This early-phase study aimed to test the safety and tolerability of a new oral drug, INCB086550, in Japanese adults with advanced solid tumors that had not responded to other treatments. Only 3 participants were enrolled before the study was terminated. The main goal was to ident…
Phase: PHASE1 • Sponsor: Incyte Biosciences Japan GK • Aim: Disease control
Last updated Apr 29, 2026 03:27 UTC